Colon Tumours Cengiz Pata, M.D

Slides:



Advertisements
Similar presentations
Surveillance/ Screening Colonoscopy for Colorectal Cancer
Advertisements

Tumors of Intestines.
Pathophysiology Colon CA. Most colorectal cancers, regardless of etiology, arise from adenomatous polyps. Polyp - a grossly visible protrusion from the.
Diagnosis.
Colon lecture John R Pender, M.D. Dept. of Surgery BSOM, East Carolina University.
Polyps – Where do they come from and what do you do with them?!
Eugen Divjak Mentor: A. Žmegač Horvat
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
COLORECTAL CARCINOMA Bernard M. Jaffe, MD Professor of Surgery Emeritus.
Colorectal Cancer Ramon Garza III, M.D.. Colorectal CA DNA Sequencing Mismatch Repair Genes Genomics Role of PCR and FISH in Colon CA.
PLWC Slide Deck Series: Understanding Colorectal Cancer Presents 2005.
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Colorectal cancer PathogenesisBy Dr. Fahd Al-Mulla.
COLORECTAL CANCER Epidemiology: CRC is the 3rd cancer killer after:
Screening and Early Diagnosis of Colorectal Cancer
Colorectal Cancer (CRC)
Colorectal cancer in Norway Maria Mai Ingvild Hvalby.
Tumors; of the large intestine I. Benign A- Adenomatous polyps; Solitary adenomatous polyp is usually acquired & occurs in patients over 40 years of age.
Tumors of the small and large intestines Maha Arafah.
Colorectal cancer Khayal AlKhayal MD,FRCSC
General Medicine Subspecialty Conference Colon Cancer Screening General Medicine Subspecialty Conference Colon Cancer Screening Selim Krim, MD Assistant.
COLORECTAL MALIGNANCIES Divina B. Esteban, M.D., FPSMO Rizal Medical Center.
大肠癌及其癌前病变 Colorectal Carcinoma and Its Precursor Lesions
Diseases of Large Bowel. Diverticulosis of the Colon I. Diverticula of the colon are acquired herniations of colonic mucosa protruding through the.
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Colorectal carcinoma Dr.Mohammadzadeh.
Colorectal cancer Khayal AlKhayal MD,FRCSC Assistant professor of Surgery Consultant Colorectal surgeon 9/11/2015Shwartz.
CONFIDENTIAL PillCam ™ COLON PillCam™ COLON has received a CE Mark, but is not cleared for marketing or available for commercial distribution in the USA.
Interventions for Clients with Colorectal Cancer
Common small and large intestinal surgical diseases Part II
Colon Cancer. Epidemiology 3 rd most common cancer in males and females. Accounts for 11% of cancer deaths. In 2000, 130,200 cases (colon and rectum).
Prevention and Health Promotion Administration May Overview of Colorectal Cancer Maryland Department of Health & Mental Hygiene Prevention and Health.
G ASTROINTESTINAL B LOCK P ATHOLOGY LECTURE 2014 Dr. Maha Arafah Dr. Ahmed Al Humaidi Benign Tumors of Intestine.
Colorectal Cancer. Colorectal cancer - statistics Leading causes of cancer death in the US Male Female Lung – 31% Lung – 25% Prostate – 11% Breast – 11%
Colon and rectal cancer
COLORECTAL CANCER Ozlem Uysal-Sonmez, MD Yeditepe University Hospital Department of Medical Oncology.
Change in bowel habits … 60 year old male Complains of progressive constipation for the past 6 months.
GI Tutorial. General Structure Mucosa –Epithelium –Lamina Propria –Muscularis Mucosa Submucosa –Connective tissue, blood vessels, nerve plexus Muscularis.
Pathology Report Colorectal Cancer Sahar Najibi April 11 th, 2008.
סרטן מעי גס אבחון מוקדם מניעה טיפול מונע ד"ר הוברט אילה מנהלת המרכז לגידולים במערכת העיכול מכון שרת הדסה עין כרם.
A 58 years old man presents with melena. What would you ask him?
Colon polyps Peter Stanich, MD
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
» LARGE INTESTINES ˃APPENDIX ˃ASCENDING COLON ˃TRANSVERSE COLON ˃DESCENDING COLON ˃SIGMOID.
Presented by : Dwi Damar Andriyani Consultant : dr. Edy Moeljono, Sp.Rad (K)RA THE LARGE BOWEL COLORECTAL TUMOUR (POLYPS) BOOK READING DAVID SUTTON VOLUME.
16/12/2012 Mr. Ravi-Kumar Stafford General Hospital1 ABC of CRC (Colo-Rectal Carcinoma) Mr Ravi-Kumar Consultant Surgeon Coloproctology, Laparoscopy &
Definition Signs & symptoms Treatment Root of the disease.
Interventions for Clients with Colorectal Cancer.
Colon Cancer. What is Colon Cancer?  Cancer that begins in the colon or rectum  The colon and rectum are both parts of the large intestine  The third.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
A Prof Of Colorectal Surgery
Case. Kreem is 53 year old man who is quite healthy with no previous illness. He has noticed changes in his bowel habits for the last few months, with.
POLYPS CHOLORECTAL CANCER M. DuBois Fennal, PhD, RN, CNS.
Large Bowel.
Benign And Malignant Tumors Of The Rectum
Tumours of the large intestine
Professor Dr. Sabeha Al-Bayati MBCHB,CABM,FRCP
27th Annual Winter CME Conference
Tumors of the colon & rectum
Irritable Bowel Syndrome
Gastrointestinal Block Pathology lecture 2016/2017
Colorectal Cancer Screening and Postoperative Follow-Up
FAMILIAL ADENOMATOUS POLYPOSIS
Tumors of the colon & rectum
James Roat, MD University of Cincinnati Division of Digestive Diseases
Polyps of the Colon and Rectum
Colonic polyps and tumors
Dr. Maha Arafah Dr. Ahmed Al Humaidi
Presentation transcript:

Colon Tumours Cengiz Pata, M.D Gastroenterology Department, Yeditepe University Istanbul

“ Colon Tumours”   ß                Benign%.....Malign

Pathogenesis of Progression from Adenoma to Carcinoma Adenoma  Neoplastic transformation of one cell ! Mutation  APC, DCC, k, RAS Deletion  5q, 17b Activation  c, myc MILD  MODERATE  SEVERE DYSPLASIA > 2 cm – Villous components   Malignancy 

Road of carcinoma

Benign Tumours = POLYPS (mostly) but may be malign ! Mucosal protrusions (= projections) into the lumen of the GI – tract.

Premalign disease of the colon Polyps Hereditary and nonhereditary polyposis syndrome Hereditary nonpolyposis syndrome İnflamatuar bowel disease

The Polyposis Syndrom’s Ú Rarely single Ú Often multiple Ú > 100 Polyps = Polyposis

Classification “ There is no unique classification “ FORM SIZE HISTOLOGY DYSPLASIA (Degree !) Hereditary X Non-hereditary NEOPLASTIC X NON-NEOPLASTIC

FORM Sessile (broad based) Pedunculated (stalk) Semi-pedunculated

SIZE + (correlation to Ca-Risk) < 1 cm ( 1 - 2 %) 1-2 cm ( 10 %) > 2 cm ( 40 - 50 %)

HISTOLOGY Tubular : inf. > 75 % in Histology is from a complex network of branching adenomatous architecture Villous : > 75 % in Histology front like surface Tubulo-villous : 50 : 50 % (not easy to distinguish)

Tubulo-adenoma

DYSPLASIA (= DEGREE) Mild:  5 % Moderate:  20% Severe: > 30 %

Polyposis Syndrome Hereditary Non-hereditary FAP · Gardner Syndrome · Turcot Syndrome  PEUTZ-JEGHERS Syndrome JUVENILE (Fam) POLYPOSİS COWDEN Syndrome Non-hereditary  CRONKHITE – CANADA Syndrome HYPERPLASTIC (= METAPLASTIC) INFLAMMATORY

EASY – SIMPLIFIED CLASSIFICATION NEOPLASTIC Adenomas Carcinomas NON-NEOPLASTIC Hamartomatous Hyperplastic Juvenile Inflammatory

More Simplified Classification ·      Four main types A ) Adenomas B ) Hamartomatous C ) Hyperplastic D ) Inflammatory ·        Rare Types Lipoma Fibroma Neurofibroma Leiomyoma Nodular Lymphoid Hyperplasia

Symptoms Most cases are asymptomatic Bleeding (increases with increased polyp size) Abdominal discomfort (rare) Obstruction

Diagnosis Barium-studies Endoscopically (Endoscopy is preferred polypectomy histologic examination

Hereditary Polyposis Syndromes

TYP LOCATION GENE TICS HISTO ASSOC. FINDINGS Ca-Risk Familial Juvenile   TYP LOCATION GENE TICS HISTO ASSOC. FINDINGS Ca-Risk   Familial Juvenile Polyposis Colon rectum AD Ham. ( - ) 8-10 % Peutz-Jeghers Syndrome Stomach, small bowel Pigmen tation 2-3% Adenoma -tous Stomach CHRP > 90 %

TYPES OF FAP GARDNER S. + Osteoma, Fibroma, Lipoma +Epidermoid-cysts TURCOT S. + Glio-, and Medulloblastoma AAPL (= before hereditary flat Adenomas) = (Attenuated Adenomatous P.) High Grade Dysplasia  5. Deka  Ca Risk > 100% !

FAP ve Gardner S

Peutz-Jeghers Syndrome Recent findings GIT + Pigmentation Mouth Hands Feet Tumours : ovarian testis

Peutz Jeghers S.

Peutz Jeghers S.

Cronkhite-Canada Syndrome Acquired, nonfamilial Middle aged adults Hamartomas + Adenomas Stomach, small bowel, colon Associated findings :  Alopecia  cutaneous pigmentation  dystrophic nails  Diarrhoea  Weight loss  Abdominal pain Ca-Risk  5%

MANAGEMENT Tubular or Villous Other Colorectal polyp       Tubular or Villous Other Tubulovillous  < 1 cm > 1 cm no investigation < 5 polyps > 5 polyps in total   Repeat in 1 year Repeat in 3 years  All clear  Repeat in 5 years

Polypectomy Operation Size < 1 cm < 2-3 cm Total < 5 polyps FAP : Prophylactic Colectomy !

Colorectal Cancer POLYP  DYSPLASIA  CANCER sequence is now generally accepted

Colorectal Cancer Second most common cancer in USA , Germany, UK, France ! After age 40 to age 80 the incidence doubles !!!

Colon Ca

RISC FACTORS Low-fiber, high fat diet Age > 40 Personal History : Colorectal adenomas Family History : Polyps Syndromes Inflammatory Bowel Disease ( CD, UC) Genital tract cancer in women Lynch Syndrome : Hereditary Nonpolypose Colon Carcinoma (HNPCC)

Lynch Syndrome : Hereditary Nonpolyposis Colon Carcinoma (HNPCC) Autosomal dominant Amsterdam criteria:3,2,1 rules (3 relative, 2 generation,1 person<50 DNA mismatch repair 6% of colorectal carcinoma Typ 2:Endometrium, stomach, hepatobiliary Ca HMSA %60 (+)

Symptoms Bleeding (Gross or occult) Change in bowel habit ; constipation, diarrhoea, decreased caliber of stool Anemia Weight loss Anorexia

Classification/Localization Rectum  60% Sigma  20% Rest colon  20%

Most Common Presentation Left sided : Bleeding Obstruction Diarrhoea Right sided : Fatique Weakness Occult blood loss Obstruction (late)

Staging - Systems TNM : Tumor / Nodes / Metastasis UICC : Union Internationale Contra Le Cancer ASTLER-COLLER : DEPTH OF İNVASİON DUKE + Lymph node metastasis

T1s No Mo Carcinoma in situ (Basal membrane intact) I a Dukes A T1 No Mo Tumor involves mucosa+submucosa I b T2 No Mo Tumor invades to muscularis propria (but not true it !!!) II Dukes B1 T3No Mo Tumor penetrates through the bowel wall Dukes B2 T4 No Mo Tumor involves viscerales peritoneum III Dukes C Tany N1-2 Mo + Regional positive lymph nodes IV Dukes D Tany Nany M1 Distant metastatic spread

Colon Ca-Survi

Prognosis by DUKE’s Staging 5 year survival rate : A : 80% B1 : 65% B2 : 43% C1 : 53% C2 : 15% D : 0%

Negative Prognostic Factors High-grade tumor Obstruction Perforation

Diagnostic Procedures and Presurgical Evaluation Laboratory : CEA, CA 19-9 TBC, Liver profile Colonoscopy Radiographs Detailed History (including family history) Physical examination (including breast+pelvic ovary+endometrium)

Therapy For cure in Duke’s A, B, C For palliation in Duke’s D Surgical Adjuvant Chemotherapy ( 5-FU / Folinasid) Palliative ( Stenosis  anus-praeterminalis)

SURGİCAL Radical tumor-resection + regional lymph node extripation Colon Hemicolectomy Sigma Transversum > resection Rectum Distance “Linea ANOCUTANEA “ cure + maintanence of fecal continence

SCREENING of Patients After age 40 annual rectal examination Annual fecal occult blood test every year after age 50 After age 50 Sigmoidoscopy every 5 years, colonoscopy every ten years Today: colonoscopy every 5 year after 50 years

Follow up in patients with positive family history

HNPCC’ da İzlem

Ulcerative colitis following